InsiderTrades

Form 4 for ELV Elevance Health

Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0001887908-26-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-03-04 2026-03-02+ ELV Kendrick Charles Morgan JR EVP, Pres, Commercial F - Tax $291.28 -1,678 15.0K -10% -$488.8K
DM 2026-03-04 2026-03-02 ELV Kendrick Charles Morgan JR EVP, Pres, Commercial A - Grant $0.00 +6,549 15.5K +74% $0
D 2026-03-04 2026-03-02 ELV Kendrick Charles Morgan JR EVP, Pres, Commercial A - Grant $0.00 +15.9K 15.9K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-02 F D 1,211 $294.07 8,905 D — — (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
2 Common Common Stock 2026-03-02 A A 4,017 $0.00 12,922 D — — (F2) Represents restricted share units. Restrictions lapse as follows: 1,339 shares on 3/2/2027, 3/2/2028 and 3/2/2029.
3 Common Common Stock 2026-03-02 A A 2,532 $0.00 15,454 D — — (F3) Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.
4 Common Common Stock 2026-03-03 F D 467 $284.03 14,987 D — — (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
5 Derivative Employee Stock Option (Right to Buy) 2026-03-02 A A 15,870 $0.00 15,870 D $294.07 · — to 2036-03-02 15,870 Common Stock (F4) The option represents a right to purchase a total of 15,870 shares, and is exercisable in three annual installments, each installment of 5,290 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.